Medulloblastoma - Pipeline Insight, 2021

SKU ID :DEL-19306977 | Published Date: 12-Oct-2021 | No. of pages: 60
Introduction Executive Summary Medulloblastoma: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Mid Stage Products (Phase II) • Comparative Analysis Drug Name: Company Name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I/II) • Comparative Analysis 177Lu-omburtamab-DTPA: Y-mAbs Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical stage products • Comparative Analysis CT 179: Curtana Pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Medulloblastoma Key Companies Medulloblastoma Key Products Medulloblastoma- Unmet Needs Medulloblastoma- Market Drivers and Barriers Medulloblastoma- Future Perspectives and Conclusion Medulloblastoma Analyst Views Medulloblastoma Key Companies Appendix
Table 1 Total Products for Medulloblastoma Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products
• Bayer • Novartis • Celgene • Y-mAbs Therapeutics • Apices Soluciones S.L. • Bristol-Myers Squibb • Oncurious NV • Eli Lilly and Company • Valent technologies • Guangdong Zhongsheng Pharmaceutical • Chimerix • Kintara Therapeutics • Curtana Pharmaceuticals • VBI Vaccines • Nurix • Oncoheroes Biosciences • Midatech
  • PRICE
  • $1500
    $4500
    Buy Now

Our Clients